Giovanni Luca Ceresoli

10.1k total citations
199 papers, 5.6k citations indexed

About

Giovanni Luca Ceresoli is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Biotechnology. According to data from OpenAlex, Giovanni Luca Ceresoli has authored 199 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Pulmonary and Respiratory Medicine, 67 papers in Oncology and 27 papers in Biotechnology. Recurrent topics in Giovanni Luca Ceresoli's work include Occupational and environmental lung diseases (79 papers), Pleural and Pulmonary Diseases (49 papers) and Lung Cancer Treatments and Mutations (38 papers). Giovanni Luca Ceresoli is often cited by papers focused on Occupational and environmental lung diseases (79 papers), Pleural and Pulmonary Diseases (49 papers) and Lung Cancer Treatments and Mutations (38 papers). Giovanni Luca Ceresoli collaborates with scholars based in Italy, United States and Spain. Giovanni Luca Ceresoli's co-authors include Armando Santoro, Paolo Andrea Zucali, Federico Cappuzzo, Lucio Crinò, Vanesa Gregorc, Stefania Bartolini, Eugenio Villa, Fabio De Vincenzo, Letizia Gianoncelli and Emmanuel Villa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Giovanni Luca Ceresoli

189 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giovanni Luca Ceresoli Italy 39 4.2k 2.2k 862 717 442 199 5.6k
Kimihiro Shimizu Japan 37 2.1k 0.5× 1.6k 0.7× 1.7k 2.0× 650 0.9× 644 1.5× 256 4.8k
Stephen L. Graziano United States 39 2.9k 0.7× 2.8k 1.3× 1.3k 1.5× 467 0.7× 459 1.0× 117 5.2k
Dennis C. Shrieve United States 44 2.2k 0.5× 1.3k 0.6× 1.2k 1.3× 897 1.3× 1.2k 2.8× 187 6.2k
Antonio Chella Italy 39 3.5k 0.8× 2.9k 1.3× 1.6k 1.9× 272 0.4× 398 0.9× 130 5.5k
Hiroyuki Katoh Japan 34 1.5k 0.4× 1.8k 0.8× 1.4k 1.6× 316 0.4× 807 1.8× 163 4.6k
Makoto Sonobe Japan 36 2.8k 0.7× 1.5k 0.7× 780 0.9× 460 0.6× 779 1.8× 224 4.8k
Ritsuko Komaki United States 32 2.4k 0.6× 1.2k 0.5× 634 0.7× 830 1.2× 638 1.4× 71 3.7k
Petr Kavan Canada 29 1.1k 0.3× 1.5k 0.7× 1.0k 1.2× 417 0.6× 390 0.9× 141 4.4k
Thomas Brunner Germany 43 1.9k 0.4× 2.9k 1.3× 1.5k 1.7× 843 1.2× 1.5k 3.4× 170 5.9k
Martin Stuschke Germany 45 4.7k 1.1× 2.5k 1.1× 1.2k 1.4× 1.4k 1.9× 2.9k 6.6× 334 8.3k

Countries citing papers authored by Giovanni Luca Ceresoli

Since Specialization
Citations

This map shows the geographic impact of Giovanni Luca Ceresoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Luca Ceresoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Luca Ceresoli more than expected).

Fields of papers citing papers by Giovanni Luca Ceresoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Luca Ceresoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Luca Ceresoli. The network helps show where Giovanni Luca Ceresoli may publish in the future.

Co-authorship network of co-authors of Giovanni Luca Ceresoli

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Luca Ceresoli. A scholar is included among the top collaborators of Giovanni Luca Ceresoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Luca Ceresoli. Giovanni Luca Ceresoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ceresoli, Giovanni Luca, Laura Mannarino, Lara Paracchini, & Federica Grosso. (2024). Pleural mesothelioma: Long-term progression-free survival with Tumor Treating Fields (TTFields) therapy case reports. SHILAP Revista de lepidopterología. 17. 100342–100342.
2.
Rossi, Giulio, Luisella Righi, Francesca Barbisan, et al.. (2024). BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report. Journal of Personalized Medicine. 14(4). 394–394. 1 indexed citations
3.
Pala, Laura, Eleonora Pagan, Tommaso De Pas, et al.. (2024). “Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.”. The Breast. 73. 103672–103672. 1 indexed citations
4.
Mensi, Carolina, et al.. (2023). Second Primary Cancers in a Population-Based Mesothelioma Registry. Cancers. 15(6). 1746–1746. 1 indexed citations
5.
Noia, Vincenzo Di, Ettore D’Argento, Sara Pilotto, et al.. (2020). Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study. Cancer Immunology Immunotherapy. 70(6). 1583–1592. 11 indexed citations
6.
7.
Vergote, Ignace, Manuel Benavides, Miklos Pless, & Giovanni Luca Ceresoli. (2018). Safety of TTFields Applied to the Torso: Meta-analysis of 176 Patients from Four Phase I-II Trials. International Journal of Radiation Oncology*Biology*Physics. 102(3). e370–e370. 3 indexed citations
8.
Pasello, Giulia, Giulia Zago, Francesca Lunardi, et al.. (2018). Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical–pathological features and intratumor heterogeneity over time. Annals of Oncology. 29(5). 1258–1265. 72 indexed citations
9.
Mencoboni, Manlio, Rosangela Filiberti, Federica Grosso, et al.. (2017). Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma. Oncology Research and Treatment. 40(6). 364–369. 3 indexed citations
10.
Passalacqua, Rodolfo, Silvia Lazzarelli, Maddalena Donini, et al.. (2017). Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01–2014). BMC Cancer. 17(1). 493–493. 4 indexed citations
11.
Novello, Silvia, Carmine Pinto, Valter Torri, et al.. (2016). The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations. Critical Reviews in Oncology/Hematology. 104. 9–20. 69 indexed citations
12.
13.
Ceresoli, Giovanni Luca & Paolo Andrea Zucali. (2015). Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma. Cancer Treatment Reviews. 41(10). 853–858. 12 indexed citations
14.
Infante, Maurizio, Silvio Cavuto, Romano Fabio Lutman, et al.. (2009). A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. American Journal of Respiratory and Critical Care Medicine. 180(5). 445–453. 273 indexed citations
15.
Baryshnikova, Ekaterina, Annarita Destro, Maurizio Infante, et al.. (2008). Molecular Alterations in Spontaneous Sputum of Cancer-Free Heavy Smokers: Results from a Large Screening Program. Clinical Cancer Research. 14(6). 1913–1919. 47 indexed citations
16.
Finocchiaro, Giovanna, Luca Toschi, I. Garassino, et al.. (2007). EGFR tyrosine kinase inhibitors: a therapy for a few, for the majority or for all non-small cell lung cancer patients?. Expert Opinion on Medical Diagnostics. 1(2). 183–191. 2 indexed citations
17.
Gregorc, Vanesa, Giovanni Luca Ceresoli, Irene Floriani, et al.. (2004). Effects of Gefitinib on Serum Epidermal Growth Factor Receptor and HER2 in Patients with Advanced Non-Small Cell Lung Cancer. Clinical Cancer Research. 10(18). 6006–6012. 37 indexed citations
18.
Cappuzzo, Federico, Vanesa Gregorc, Elisa Rossi, et al.. (2003). Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC. Journal of Clinical Oncology. 21(14). 2658–2663. 175 indexed citations
19.
Ceresoli, Giovanni Luca, Stefania Dell’Oro, Paolo Passoni, & Eugenio Villa. (2000). Phase II study of paclitaxel and epirubicin as first-line treatment in patients with metastatic nonsmall cell lung carcinoma. Cancer. 89(1). 89–96. 6 indexed citations
20.
Ceresoli, Giovanni Luca, et al.. (1996). Excitotoxic lesions of the rat striatum: different responses of kynurenine pathway enzymes during ontogeny. Developmental Brain Research. 92(1). 61–69. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimihiro Shimizu Breakdown of academic impact, for papers by Stephen L. Graziano Breakdown of academic impact, for papers by Dennis C. Shrieve Breakdown of academic impact, for papers by Antonio Chella Breakdown of academic impact, for papers by Hiroyuki Katoh Breakdown of academic impact, for papers by Makoto Sonobe Breakdown of academic impact, for papers by Ritsuko Komaki Breakdown of academic impact, for papers by Petr Kavan Breakdown of academic impact, for papers by Thomas Brunner Breakdown of academic impact, for papers by Martin Stuschke
Rankless by CCL
2026